Concepedia

Xuebo Lu

XL

Statistics

Publications

4

Citations

80

H-Index

4

Active since

2021

Affiliations

China-US (Henan) Hormel Cancer Institute(Current)

Zhengzhou University

Henan Cancer Hospital

Xuebo Lu is an author at China-US (Henan) Hormel Cancer Institute specializing in tumor biology, tumor microenvironment, and drug discovery.

ORCID

Top concepts

Publications per year

2021–2023

4

Publications

4

Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4

Yaxing Wei, Wenjie Wu, Yanan Jiang et al. · British Journal of Cancer · 2021 · 26 citations · Full text

Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A

Zhuo Bao, Ang Li, Xuebo Lu et al. · Cell Death and Disease · 2022 · 26 citations · Full text

Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC

Mingzhu Li, Lina Duan, Wenjie Wu et al. · Oncogenesis · 2023 · 15 citations · Full text

, , +13

Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2

Zitong Wang, Yingying Chen, Xiaoyu Li et al. · Cancers · 2022 · 13 citations · Full text

1–4 of 4